The University of Southampton
University of Southampton Institutional Repository

Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England

Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England
Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England

Background: Patients with underlying cardiovascular disease and coronavirus disease 2019 (COVID-19) infection are at increased risk of morbidity and mortality. Objectives: This study was designed to characterize the presenting profile and outcomes of patients hospitalized with acute coronary syndrome (ACS) and COVID-19 infection. Methods: This observational cohort study was conducted using multisource data from all acute NHS hospitals in England. All consecutive patients hospitalized with diagnosis of ACS with or without COVID-19 infection between 1 March and 31 May 2020 were included. The primary outcome was in-hospital and 30-day mortality. Results: A total of 12 958 patients were hospitalized with ACS during the study period, of which 517 (4.0%) were COVID-19-positive and were more likely to present with non-ST-elevation acute myocardial infarction. The COVID-19 ACS group were generally older, Black Asian and Minority ethnicity, more comorbid and had unfavourable presenting clinical characteristics such as elevated cardiac troponin, pulmonary oedema, cardiogenic shock and poor left ventricular systolic function compared with the non-COVID-19 ACS group. They were less likely to receive an invasive coronary angiography (67.7% vs 81.0%), percutaneous coronary intervention (PCI) (30.2% vs 53.9%) and dual antiplatelet medication (76.3% vs 88.0%). After adjusting for all the baseline differences, patients with COVID-19 ACS had higher in-hospital (adjusted odds ratio (aOR): 3.27; 95% confidence interval (CI): 2.41–4.42) and 30-day mortality (aOR: 6.53; 95% CI: 5.1–8.36) compared to patients with the non-COVID-19 ACS. Conclusion: COVID-19 infection was present in 4% of patients hospitalized with an ACS in England and is associated with lower rates of guideline-recommended treatment and significant mortality hazard.

England, acute coronary syndrome, coronavirus disease 2019, mortality, pandemic
0954-6820
88-100
Rashid, Muhammad
f974c0d2-bd55-4d93-940e-1cce3dd0fd59
Wu, Jianhua
d1e83015-b7d2-4404-847e-c6f73e281759
Timmis, Adam
afa86b24-5997-4e05-a891-ccaa20c90f20
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Clarke, Sarah
3373cf1a-6d98-4a90-873c-aa8ea6801e7f
Zaman, Azfar
1eb39d94-fdb9-466b-ab6c-7613255baf80
Nolan, James
1cdb1e12-958f-4b04-a730-242dd48591b1
Shoaib, Ahmad
87d9fdcb-a5ce-4379-8280-3115040dc364
Mohamed, Mohamed O
c9566561-5ab5-4d7b-b05d-079ebde7a279
Belder, Mark A.
3d0eff51-f1d1-41a7-aac1-e193db082360
Deanfield, John
3ffa04cf-a239-4dd7-8d77-dfc9cfe716fd
Gale, Chris P.
96b5706c-fd86-4b41-9568-3d917ef2c805
Mamas, Mamas A.
41515b72-75ff-4922-bb9f-8f9c63f9f5af
Rashid, Muhammad
f974c0d2-bd55-4d93-940e-1cce3dd0fd59
Wu, Jianhua
d1e83015-b7d2-4404-847e-c6f73e281759
Timmis, Adam
afa86b24-5997-4e05-a891-ccaa20c90f20
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Clarke, Sarah
3373cf1a-6d98-4a90-873c-aa8ea6801e7f
Zaman, Azfar
1eb39d94-fdb9-466b-ab6c-7613255baf80
Nolan, James
1cdb1e12-958f-4b04-a730-242dd48591b1
Shoaib, Ahmad
87d9fdcb-a5ce-4379-8280-3115040dc364
Mohamed, Mohamed O
c9566561-5ab5-4d7b-b05d-079ebde7a279
Belder, Mark A.
3d0eff51-f1d1-41a7-aac1-e193db082360
Deanfield, John
3ffa04cf-a239-4dd7-8d77-dfc9cfe716fd
Gale, Chris P.
96b5706c-fd86-4b41-9568-3d917ef2c805
Mamas, Mamas A.
41515b72-75ff-4922-bb9f-8f9c63f9f5af

Rashid, Muhammad, Wu, Jianhua, Timmis, Adam, Curzen, Nick, Clarke, Sarah, Zaman, Azfar, Nolan, James, Shoaib, Ahmad, Mohamed, Mohamed O, Belder, Mark A., Deanfield, John, Gale, Chris P. and Mamas, Mamas A. (2021) Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. Journal of Internal Medicine, 290 (1), 88-100. (doi:10.1111/joim.13246).

Record type: Article

Abstract

Background: Patients with underlying cardiovascular disease and coronavirus disease 2019 (COVID-19) infection are at increased risk of morbidity and mortality. Objectives: This study was designed to characterize the presenting profile and outcomes of patients hospitalized with acute coronary syndrome (ACS) and COVID-19 infection. Methods: This observational cohort study was conducted using multisource data from all acute NHS hospitals in England. All consecutive patients hospitalized with diagnosis of ACS with or without COVID-19 infection between 1 March and 31 May 2020 were included. The primary outcome was in-hospital and 30-day mortality. Results: A total of 12 958 patients were hospitalized with ACS during the study period, of which 517 (4.0%) were COVID-19-positive and were more likely to present with non-ST-elevation acute myocardial infarction. The COVID-19 ACS group were generally older, Black Asian and Minority ethnicity, more comorbid and had unfavourable presenting clinical characteristics such as elevated cardiac troponin, pulmonary oedema, cardiogenic shock and poor left ventricular systolic function compared with the non-COVID-19 ACS group. They were less likely to receive an invasive coronary angiography (67.7% vs 81.0%), percutaneous coronary intervention (PCI) (30.2% vs 53.9%) and dual antiplatelet medication (76.3% vs 88.0%). After adjusting for all the baseline differences, patients with COVID-19 ACS had higher in-hospital (adjusted odds ratio (aOR): 3.27; 95% confidence interval (CI): 2.41–4.42) and 30-day mortality (aOR: 6.53; 95% CI: 5.1–8.36) compared to patients with the non-COVID-19 ACS. Conclusion: COVID-19 infection was present in 4% of patients hospitalized with an ACS in England and is associated with lower rates of guideline-recommended treatment and significant mortality hazard.

Text
joim.13246 - Version of Record
Download (1MB)

More information

Accepted/In Press date: 19 January 2021
e-pub ahead of print date: 13 March 2021
Published date: 1 July 2021
Keywords: England, acute coronary syndrome, coronavirus disease 2019, mortality, pandemic

Identifiers

Local EPrints ID: 452466
URI: http://eprints.soton.ac.uk/id/eprint/452466
ISSN: 0954-6820
PURE UUID: a5b42d9c-91ac-4bac-aeda-95d89e501101
ORCID for Nick Curzen: ORCID iD orcid.org/0000-0001-9651-7829

Catalogue record

Date deposited: 11 Dec 2021 11:04
Last modified: 17 Mar 2024 03:02

Export record

Altmetrics

Contributors

Author: Muhammad Rashid
Author: Jianhua Wu
Author: Adam Timmis
Author: Nick Curzen ORCID iD
Author: Sarah Clarke
Author: Azfar Zaman
Author: James Nolan
Author: Ahmad Shoaib
Author: Mohamed O Mohamed
Author: Mark A. Belder
Author: John Deanfield
Author: Chris P. Gale
Author: Mamas A. Mamas

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×